Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1975 1
1976 3
1977 1
1978 1
1979 3
1980 2
1981 2
1982 6
1983 15
1984 10
1985 13
1986 7
1987 23
1988 22
1989 25
1990 44
1991 85
1992 87
1993 117
1994 149
1995 156
1996 159
1997 153
1998 161
1999 186
2000 252
2001 209
2002 229
2003 250
2004 262
2005 260
2006 291
2007 299
2008 286
2009 329
2010 382
2011 420
2012 437
2013 544
2014 535
2015 533
2016 511
2017 502
2018 1456
2019 1751
2020 2055
2021 2314
2022 2373
2023 2192
2024 901

Text availability

Article attribute

Article type

Publication date

PubMed for id: 594

18,626 results

Results by year

Filters applied: . Clear all
Page 1
Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition).
Jin YH, Zeng XT, Liu TZ, Bai ZM, Dou ZL, Ding DG, Fan ZL, Han P, Huang YR, Huang X, Li M, Li XD, Li YN, Li XH, Liang CZ, Liu JM, Ma HS, Qi J, Shi JQ, Wang J, Wang DL, Wang ZP, Wang YY, Wang YB, Wei Q, Xia HB, Xing JC, Yan SY, Zhang XP, Zheng GY, Xing NZ, He DL, Wang XH; Chinese Urological Doctor Association (CUDA), Urological Association of Chinese Research Hospital Association (CRHA-UA), Uro-Health Promotive Association of China International Exchange, Promotive Association for Medical, Health Care (CPAM-UHPA). Jin YH, et al. Mil Med Res. 2022 Aug 17;9(1):44. doi: 10.1186/s40779-022-00406-y. Mil Med Res. 2022. PMID: 35978389 Free PMC article.
ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer: 2021 Update.
Expert Panel on Urological Imaging; Allen BC, Oto A, Akin O, Alexander LF, Froemming AT, Fulgham PF, Halpern DJ, Gettle LM, Maranchie JK, Patel BN, Patlas MN, Schieda N, Solanki A, Turkbey IB, Venkatesan AM, Yoo DC, Lockhart ME. Expert Panel on Urological Imaging, et al. J Am Coll Radiol. 2021 May;18(5S):S126-S138. doi: 10.1016/j.jacr.2021.02.011. J Am Coll Radiol. 2021. PMID: 33958107 Review.
[French ccAFU guidelines - update 2020-2022: bladder cancer].
Rouprêt M, Pignot G, Masson-Lecomte A, Compérat E, Audenet F, Roumiguié M, Houédé N, Larré S, Brunelle S, Xylinas E, Neuzillet Y, Méjean A. Rouprêt M, et al. Prog Urol. 2020 Nov;30(12S):S78-S135. doi: 10.1016/S1166-7087(20)30751-X. Prog Urol. 2020. PMID: 33349431 French.
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.
Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, Hernández V, Linares Espinós E, Lorch A, Neuzillet Y, Rouanne M, Thalmann GN, Veskimäe E, Ribal MJ, van der Heijden AG. Witjes JA, et al. Eur Urol. 2021 Jan;79(1):82-104. doi: 10.1016/j.eururo.2020.03.055. Epub 2020 Apr 29. Eur Urol. 2021. PMID: 32360052 Review.
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chang S, Downs TM, Efstathiou JA, Friedlander T, Greenberg RE, Guru KA, Guzzo T, Herr HW, Hoffman-Censits J, Hoimes C, Inman BA, Jimbo M, Kader AK, Lele SM, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Preston MA, Sexton WJ, Siefker-Radtke AO, Tward J, Wright JL, Gurski LA, Johnson-Chilla A. Flaig TW, et al. J Natl Compr Canc Netw. 2020 Mar;18(3):329-354. doi: 10.6004/jnccn.2020.0011. J Natl Compr Canc Netw. 2020. PMID: 32135513
18,626 results
You have reached the last available page of results. Please see the User Guide for more information.